Shane Schaffer
About
Shane Schaffer is from Kansas City, Kansas, United States. Shane is currently Chairman and CEO at Cingulate Inc., located in United States. In Shane's previous role as a Managing Director at Sabre Scientific Solutions, Shane worked in until Dec 2012. Prior to joining Sabre Scientific Solutions, Shane was a Director, National Acounts at Pri-Med Access and held the position of Director, National Acounts. Prior to that, Shane was a Senior Marketing Executive at Sanofi from Jan 2004 to Jan 2007. Shane started working as Marketing Executive at Novartis in East Hanover, NJ in Jun 2001. From Jul 2000 to Jun 2001, Shane was Chief Fellow at Rutgers Pharmaceutical Industry Fellowship Program. Prior to that, Shane was a Post-Doctoral Fellow, Pharmaceutical Industry at Pfizer (Formerly Warner-Lambert Parke Davis) from Jan 1999 to Jan 2001. Shane started working as Student at University of Kansas School of Pharmacy in Jan 1996.
You can find Shane Schaffer's email at finalscout.com. FinalScout is a professional database with business professional profiles and company profiles.
Shane Schaffer's current jobs
Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. We aim to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), we believe there are multiple therapeutic areas where our PTR technology may be employed to develop additional product candidates, notably anxiety disorders.